贝利单抗(Benlysta)是近半个世纪以来的第一种狼疮新药，去年欧洲药物管理局已经批准该药物的上市申请。
基于302个网页-相关网页
BENLYSTA has successfully met its primary endpoint in two pivotal Phase 3 trials in systemic lupus.
BENLYSTA已经成功地达到其主要终点的两个关键第三阶段试验的系统性。
youdao
Benlysta works by targeting a protein called BLISS that came out of HGS' gene databases.
FORBES: Health Care
In smaller studies, Benlysta had failed to provide a benefit across all patients with lupus.
Those receiving Benlysta during clinical studies reported more deaths and serious infections compared with placebo.
FORBES: Human Genome Sciences' Benlysta Approved To Treat Lupus
应用推荐
模块上移
模块下移
不移动